|
Valoración de DCF de Alquyl Amines Chemicals Limited (alquilamina.ns)
IN | Basic Materials | Chemicals - Specialty | NSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Alkyl Amines Chemicals Limited (ALKYLAMINE.NS) Bundle
Como inversor o analista, esta calculadora DCF (alquilaminens) sirve como su recurso esencial para una valoración precisa. Con datos reales de Alquyl Amines Chemicals Limited ya integrados, puede ajustar los pronósticos y observar instantáneamente los efectos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9,730.5 | 12,231.2 | 15,236.1 | 16,823.3 | 14,345.4 | 15,993.5 | 17,830.9 | 19,879.5 | 22,163.4 | 24,709.8 |
| Revenue Growth, % | 0 | 25.7 | 24.57 | 10.42 | -14.73 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 |
| EBITDA | 2,968.7 | 4,360.9 | 3,401.5 | 3,570.5 | 2,647.0 | 4,099.6 | 4,570.6 | 5,095.7 | 5,681.1 | 6,333.8 |
| EBITDA, % | 30.51 | 35.65 | 22.33 | 21.22 | 18.45 | 25.63 | 25.63 | 25.63 | 25.63 | 25.63 |
| Depreciation | 269.1 | 290.6 | 347.5 | 451.7 | 589.2 | 454.7 | 506.9 | 565.2 | 630.1 | 702.5 |
| Depreciation, % | 2.77 | 2.38 | 2.28 | 2.69 | 4.11 | 2.84 | 2.84 | 2.84 | 2.84 | 2.84 |
| EBIT | 2,699.6 | 4,070.2 | 3,054.0 | 3,118.8 | 2,057.8 | 3,644.9 | 4,063.6 | 4,530.5 | 5,051.0 | 5,631.3 |
| EBIT, % | 27.74 | 33.28 | 20.04 | 18.54 | 14.34 | 22.79 | 22.79 | 22.79 | 22.79 | 22.79 |
| Total Cash | 312.5 | 1,551.6 | 615.3 | 192.6 | 303.9 | 742.1 | 827.3 | 922.4 | 1,028.4 | 1,146.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,642.2 | 2,279.9 | 2,767.4 | 2,584.2 | 2,217.3 | 2,702.8 | 3,013.4 | 3,359.6 | 3,745.5 | 4,175.8 |
| Account Receivables, % | 16.88 | 18.64 | 18.16 | 15.36 | 15.46 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 |
| Inventories | 836.7 | 1,219.0 | 1,645.3 | 1,836.6 | 1,719.7 | 1,671.9 | 1,864.0 | 2,078.1 | 2,316.9 | 2,583.0 |
| Inventories, % | 8.6 | 9.97 | 10.8 | 10.92 | 11.99 | 10.45 | 10.45 | 10.45 | 10.45 | 10.45 |
| Accounts Payable | 707.7 | 1,789.7 | 2,284.7 | 1,897.2 | 1,719.0 | 1,924.4 | 2,145.5 | 2,391.9 | 2,666.7 | 2,973.1 |
| Accounts Payable, % | 7.27 | 14.63 | 15 | 11.28 | 11.98 | 12.03 | 12.03 | 12.03 | 12.03 | 12.03 |
| Capital Expenditure | -772.8 | -1,561.9 | -2,469.5 | -3,034.2 | -1,223.2 | -2,030.6 | -2,263.9 | -2,524.0 | -2,814.0 | -3,137.3 |
| Capital Expenditure, % | -7.94 | -12.77 | -16.21 | -18.04 | -8.53 | -12.7 | -12.7 | -12.7 | -12.7 | -12.7 |
| Tax Rate, % | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 |
| EBITAT | 2,364.9 | 3,000.1 | 2,273.4 | 2,311.2 | 1,513.1 | 2,794.8 | 3,115.9 | 3,473.8 | 3,872.9 | 4,317.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 90.0 | 1,790.8 | -267.5 | -666.9 | 1,184.8 | 986.5 | 1,077.4 | 1,201.1 | 1,339.1 | 1,493.0 |
| WACC, % | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 | 8.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4,738.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1,553 | |||||||||
| Terminal Value | 35,374 | |||||||||
| Present Terminal Value | 23,646 | |||||||||
| Enterprise Value | 28,384 | |||||||||
| Net Debt | -272 | |||||||||
| Equity Value | 28,657 | |||||||||
| Diluted Shares Outstanding, MM | 51 | |||||||||
| Equity Value Per Share | 559.96 |
Benefits You Will Receive
- Adjustable Forecast Inputs: Seamlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Comprehensive Data: Pre-filled financial information for Alkyl Amines Chemicals Limited (ALKYLAMINENS) to facilitate your analysis.
- Instant DCF Outputs: The template automatically computes Net Present Value (NPV) and intrinsic value for you.
- Tailored and Professional: A sophisticated Excel model designed to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, assessing strategies, and optimizing efficiency.
Key Features
- Real-Time ALKYLAMINENS Data: Pre-loaded with Alkyl Amines Chemicals Limited’s historical financials and future projections.
- Completely Customizable Inputs: Modify revenue growth rates, profit margins, WACC, tax rates, and capital expenditure assumptions.
- Dynamic Valuation Framework: Automatically updates Net Present Value (NPV) and intrinsic value based on your parameters.
- Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
- User-Centric Interface: Intuitive, organized, and suitable for both industry professionals and novices.
How It Functions
- Download the Template: Gain immediate access to the Excel-based ALKYLAMINENS DCF Calculator.
- Enter Your Assumptions: Modify the yellow-highlighted fields for growth rates, WACC, profit margins, and more.
- Real-Time Calculations: The model automatically recalculates the intrinsic value of Alkyl Amines Chemicals Limited.
- Experiment with Scenarios: Test various assumptions to assess changes in potential valuation.
- Evaluate and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose This Calculator for Alkyl Amines Chemicals Limited (ALKYLAMINENS)?
- Designed for Industry Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Actual Financial Data: Alkyl Amines Chemicals Limited’s historical and projected financials integrated for precision.
- Flexible Scenario Analysis: Effortlessly evaluate various forecasts and assumptions.
- Intuitive Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Comprehensive step-by-step guidance ensures a smooth experience.
Who Can Benefit from Alkyl Amines Chemicals Limited (ALKYLAMINENS)?
- Individual Investors: Gain insights to make well-informed decisions about investing in Alkyl Amines Chemicals Limited stock.
- Financial Analysts: Simplify valuation methodologies with comprehensive, ready-to-use financial models.
- Consultants: Provide clients with accurate and timely valuation advice related to Alkyl Amines Chemicals Limited.
- Business Owners: Learn the valuation methods applied to large companies like Alkyl Amines to inform your business strategies.
- Finance Students: Acquire practical knowledge of valuation techniques through hands-on experience with real data and case studies.
Contents of the Template
- Pre-Filled Data: Features Alkyl Amines Chemicals Limited's historical financial data and projections.
- Discounted Cash Flow Model: A customizable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A specific worksheet for calculating WACC based on your inputs.
- Key Financial Ratios: Assess Alkyl Amines Chemicals Limited's profitability, efficiency, and leverage.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation metrics.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.